Written Testimony Supporting HB 3286: PDL Exceptions

We support HB 3286, which would create new Medicaid prescription drug patient protections by adding exceptions to the state’s preferred drug list (PDL), expand access to prescribed medications, as well as promote greater accountability within the state’s Vendor Drug Program (VDP) and Drug Utilization Review (DUR) Board.

This bill is crucial as it gives Medicaid patients access to a similar exception process that patients have in the private health insurance market. Unfortunately, Texas Medicaid patients do not currently have these same protections and are often forced off medications that work for them, often causing delays and denials of care.

Read the written testimony.

Become a Member

Membership with TAHP is an invaluable tool for integrating, building relationships, exchanging information and best practices, and promoting your services. You will be well-armed with the most timely and accurate information, strong relationships with key Texas leaders, and access to seasoned policy and regulatory experts.